# Study to Find Maintenance Dose for Periodic Administration of ASP3550

> **NCT01261572** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 155 (actual)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **DRUG:** degarelix

## Key facts

- **NCT ID:** NCT01261572
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10-12
- **Primary completion:** 2012-04-24
- **Final completion:** 2012-04-24
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2024-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01261572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01261572, "Study to Find Maintenance Dose for Periodic Administration of ASP3550". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01261572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*